Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2017

Aug 17, 2017

30597_dirs_2017-08-17_3c5a3d08-dbfa-4f14-a0d7-b8c4f0b61cea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2017-08-17

Reporting Person: Conroy Kevin T (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-17 Common Stock M 9242 $10.82 Acquired 830052 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-08-17 Stock Option (right to buy) $10.82 M 9242 Disposed 2023-02-22 Common Stock (106000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 24990 Indirect
Common Stock 65189 Indirect

Footnotes

F1: These options vest and become exercisable in four equal annual installments beginning on February 22, 2014.